First report of a very rare complication in a case of nonsmall cell lung carcinoma

While immune checkpoint inhibitors like pembrolizumab are promising agents for nonsmall cell lung carcinoma treatment, increased use is leading to increased immune-related adverse events, including endocrinopathies such as adrenal insufficiency. https://bit.ly/3iMfhUk

Detalles Bibliográficos
Autores principales: Moreira, Inês, Vilariça, Ana Sofia, Alves, Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753643/
https://www.ncbi.nlm.nih.gov/pubmed/35035567
http://dx.doi.org/10.1183/20734735.0107-2021
_version_ 1784632134826196992
author Moreira, Inês
Vilariça, Ana Sofia
Alves, Paula
author_facet Moreira, Inês
Vilariça, Ana Sofia
Alves, Paula
author_sort Moreira, Inês
collection PubMed
description While immune checkpoint inhibitors like pembrolizumab are promising agents for nonsmall cell lung carcinoma treatment, increased use is leading to increased immune-related adverse events, including endocrinopathies such as adrenal insufficiency. https://bit.ly/3iMfhUk
format Online
Article
Text
id pubmed-8753643
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-87536432022-01-13 First report of a very rare complication in a case of nonsmall cell lung carcinoma Moreira, Inês Vilariça, Ana Sofia Alves, Paula Breathe (Sheff) Expert Opinion While immune checkpoint inhibitors like pembrolizumab are promising agents for nonsmall cell lung carcinoma treatment, increased use is leading to increased immune-related adverse events, including endocrinopathies such as adrenal insufficiency. https://bit.ly/3iMfhUk European Respiratory Society 2021-12 /pmc/articles/PMC8753643/ /pubmed/35035567 http://dx.doi.org/10.1183/20734735.0107-2021 Text en Copyright ©ERS 2022 https://creativecommons.org/licenses/by-nc/4.0/Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Expert Opinion
Moreira, Inês
Vilariça, Ana Sofia
Alves, Paula
First report of a very rare complication in a case of nonsmall cell lung carcinoma
title First report of a very rare complication in a case of nonsmall cell lung carcinoma
title_full First report of a very rare complication in a case of nonsmall cell lung carcinoma
title_fullStr First report of a very rare complication in a case of nonsmall cell lung carcinoma
title_full_unstemmed First report of a very rare complication in a case of nonsmall cell lung carcinoma
title_short First report of a very rare complication in a case of nonsmall cell lung carcinoma
title_sort first report of a very rare complication in a case of nonsmall cell lung carcinoma
topic Expert Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753643/
https://www.ncbi.nlm.nih.gov/pubmed/35035567
http://dx.doi.org/10.1183/20734735.0107-2021
work_keys_str_mv AT moreiraines firstreportofaveryrarecomplicationinacaseofnonsmallcelllungcarcinoma
AT vilaricaanasofia firstreportofaveryrarecomplicationinacaseofnonsmallcelllungcarcinoma
AT alvespaula firstreportofaveryrarecomplicationinacaseofnonsmallcelllungcarcinoma

Ejemplares similares